Journal article

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, Michael S Anglesio, Steve E Kalloger, Winnie Yang, Alireza Heravi-Moussavi, Ryan Giuliany, Christine Chow, John Fee, Abdalnasser Zayed, Leah Prentice, Nataliya Melnyk, Gulisa Turashvili, Allen D Delaney Show all

New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2010

Grants

Awarded by CIHR


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by National Cancer Institute, National Institutes of Health


Funding Acknowledgements

Supported by grants from the British Columbia (BC) Cancer Foundation and the Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation (to the OvCaRe ovarian cancer research team in Vancouver) and the Canadian Institutes of Health Research (CIHR). The Michael Smith Genome Sciences Centre (MSGSC), with which many of the authors are affiliated, is funded by Genome Canada, and OvCaRe and the MSGSC are also funded by the Michael Smith Foundation for Health Research (MSFHR). Salary support is provided by MSFHR to Drs. Shah, Marra, Jones, and Huntsman; by the CIHR Training Program for Clinician Scientists in Molecular Oncologic Pathology to Drs. Al-Agha and Turashvili (STP-53912); by the CIHR Bioinformatics Training Program for Health Research to Mr. McPherson and Mr. Ha; by the Canadian Breast Cancer Foundation to Dr. Shah; and a Canada Research Chair in Molecular Oncology to Dr. Aparicio. The Genetic Pathology Evaluation Centre, which constructed the tissue microarrays, has received nondirected research grants from Sanofi-Aventis, Canada. The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (VGH, Banque de Tissus et de Donnees of the Reseau de Recherche sur le Cancer of the Fonds de la Recherche en Sante du Quebec, affiliated with the Canadian Tumor Repository Network), and by a grant (DAMD17-O1-1-0729) from the U.S. Army Medical Research and Materiel Command; grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to AOCS; and grants from the National Cancer Institute, National Institutes of Health (RO1CA103937 and RO1CA129080).